JPRN-UMIN000025176已完成未知
Efficacy, tolerability, and safety of transition from beraprost to selexipag in patients with pulmonary arterial hypertension. - Efficacy, tolerability, and safety of transition from beraprost to selexipag
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who added newly concomitant drugs within last 3 months 2. Patients who is expected to intolerable selexipag 3. Patients who had clinically unstable right heart failure within the last 3 months
研究者
相似试验
尚未招募
3 期
B/F/TAF to DTG/3TC Switch StudyHIV/AIDSPACTR202404870570433niversity of Nairobi240
进行中（未招募）
1 期
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120
已完成
不适用
Preventing hospital readmissions and loss of functional ability in high risk older adults: a randomised controlled trialHospital readmissions and loss of functional ability in older adults at high risk of hospital readmissionPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationACTRN12608000202369Professor Mary Courtney328
已完成
4 期
To access the safety and efficacy of Travacom in patients with uncontrolled intraocular pressureCTRI/2010/091/000523Alcon laboratoriesIndia Pvt Ltd600
已完成
不适用
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30